Your search relates to more than one category
Stock Market Analysis (Free subscription) | yesterday
CTIC Technical Analysis - The following is Cell Therapeutics ( CTIC ) stock technical analysis for December 8, 2009 Cell Therapeutics, Inc ( CTIC ) Support & Resistance Levels - 12/8/09 Resistance Levels: 1.28, $1.31, $1.40-$1.50 Support Levels: $1.21, $1.13, $1.08, $1.00 Chart - http://stockcharts.com/ Discuss Stocks - http://stockstobuy.org Cell Therapeutics, Inc ( CTIC...
SchaeffersResearch.com Trading Floor Blog (Free subscription) | yesterday
As explained in our education section, short interest is a useful sentiment indicator that measures the level of investor pessimism toward a stock...( Read More )
Volume Spike Investor (Free subscription) | 12/07/2009
Cell Therapeutics, Inc. (NASDAQ: CTIC) is trading up after it disclosed data from the pivotal phase III EXTEND clinical trial of pixantrone in relapsed or refractory, aggressive non-Hodgkin’s lymphoma patients who have failed 2 or more prior therapies. The company noted that updated analysis with additional follow-up data were conducted and support the initial clinical [...]
Stock Market Analysis (Free subscription) | 12/05/2009
CTIC Technical Analysis - The following is Cell Therapeutics ( CTIC ) stock technical analysis for December 7, 2009 Cell Therapeutics, Inc ( CTIC ) Support & Resistance Levels - 12/7/09 Resistance Levels: $1.21, 1.28, $1.31 Support Levels: $1.12, $1.07, $1.00 Chart - http://stockcharts.com/ Discuss Stocks - http://stockstobuy.org Cell Therapeutics, Inc ( CTIC ) surged up to...
SchaeffersResearch.com Trading Floor Blog (Free subscription) | 12/02/2009
As explained in our education section, short interest is a useful sentiment indicator that measures the level of investor pessimism toward a stock...( Read More )
Stock Market Analysis (Free subscription) | 8 hours ago
Wednesday, during regular trading hours, there were many stocks that continued to break out to the upside. Below is a list of stocks that are worth watching for December 10, 2009. Also, check out some of the biggest stock gainers of the Day. You can also find previous stocks to buy reports - Right Here Stocks to Watch - 12/10/09 - Stock Market Ideas Discuss Stocks - http://stockstobuy.org Netlist Inc....
Stock Market Analysis (Free subscription) | 12/07/2009
Below is a list of some of the largest stock gainers and losers so far in pre market for December 7, 2009. Check out my Hot Stocks to Watch page for the latest updates. Pre Market Stock Gainers - 12/7/09 International Royalty Corp (ROY) - International Royalty informed by Franco-Nevada Corporation of its intention to make an offer for IRC shares Cyclacel Pharmaceuticals, Inc. (CYCC) - Cyclacel...
The Earth Times Online Newspaper (Free subscription) | 12/08/2009
NEW ORLEANS, Dec. 8 -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity...
Red Orbit (Free subscription) | 12/08/2009
NEW ORLEANS, Dec. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today an abstract to be published online at the journal Blood website by M. Hacker, et al.
PR News Wire (Free subscription) | 12/08/2009
NEW ORLEANS, Dec. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's...
24/7 Wall St. (Free subscription) | 12/07/2009
These are this morning’s top day trader and active trader alerts. We have more detailed data and analysis over at VSInvestor.com via links on each story and stock: Apple Inc. (NASDAQ: AAPL) is still under a sell signal and under its 50-day moving average for the first time since April. Sprint Nextel Corporation (NYSE: S) is up [...]
Radon Mitigation Pittsburgh (Free subscription) | 12/02/2009
( EMAILWIRE.COM , December 02, 2009 ) Dallas, TX - Cell Therapeutics, Inc. (NASDAQ:CTIC) climbed 5.73% to $1.09. The stock hit an intraday high and an intraday low of $1.09 and $1.05 respectively. In the last six months the stock went down over 48%. Cell Therapeutics, Inc. (Cell Therapeutics) develops, acquires and commercializes treatments for cancer. The Company's...
Red Orbit (Free subscription) | 12/02/2009
SEATTLE, Dec. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that Ruth Pettengell, M.D. of St.
PR News Wire (Free subscription) | 12/02/2009
SEATTLE, Dec. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the...
PR News Wire (Free subscription) | 12/02/2009
SEATTLE, Dec. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the...
